以百白破疫苗为基础的联合疫苗研究进展和展望

整理文档很辛苦,赏杯茶钱您下走!

免费阅读已结束,点击下载阅读编辑剩下 ...

阅读已结束,您可以下载文档离线阅读编辑

资源描述

以百白破疫苗为基础的联合疫苗研究进展和展望作者:卫辰,侯启明,张庶民,陈平纡,马霄作者单位:卫辰,侯启明,张庶民,马霄(中国食品药品检定研究院血清室卫生部生物技术产品检定方法及其标准化重点实验室,北京,100050),陈平纡(兰州生物制品研究所有限责任公司)刊名:中华预防医学杂志英文刊名:ChineseJournalofPreventiveMedicine年,卷(期):2012,46(9)参考文献(23条)1.deMelkerHE;SchellekensJF;NeppelenbroekSEReemergenceofpertussisinthehighlyvaccinatedpopulationoftheNetherlands:observationsonsurveillancedata2000(04)2.骆鹏;张庶民百日咳免疫控制研究进展[期刊论文]-中国公共卫生2010(05)3.StanleyAP;WalterAO;梁晓峰;罗凤基,封多佳疫苗学20114.DeckerMD;EdwardsKM;BradleyRComparativetrialininfantsoffourconjugateHaemophilusinfluenzaetypebvaccines1992(2Pt1)5.ShinefieldH;BlackS;ThearMSafetyandimmunogenicityofameasles,mumps,rubellaandvaricellavaccinegivenwithcombinedHaemophilusinfluenzaetypebconjugate/hepatitisBvaccinesandcombineddiphtheria-tetanusacellularpertussisvaccines2006(04)6.MawasF;DickinsonR;Douglas-BardsleyAImmuneinteractionbetweencomponentsofacellularpertussis-diphtheria-tetanus(DTaP)vaccineandhaemophilusinfluenzaeb(Hib)conjugatevaccineinaratmodel[外文期刊]2006(17)7.EskolaJ;WardJ;DaganRCombinedvaccinationofhaemophilusinfluenzaetypebconjugateanddiphtheria-tetanus-pertussiscontainingacellularpertussis1999(9195)8.CarlssonRM;ClaessonBA;FagerlundEAntibodypersistenceinfive-year-oldchildrenwhoreceivedapentavalentcombinationvaccineininfancy2002(06)9.LiRC;LiFX;LiYPImmunogenicityandsafetyofapentavalentacellularpertussiscombinedvaccineincludingdiphtheria,tetanus,inactivatedpoliovirusandconjugatedHaemophilusInfluenzaetypebpolysaccharideforprimaryvaccinationat2,3,4or3,4,5monthsofageininfantsinChina2011(10)10.LiRC;LiFX;LiYPAntibodypersistenceat18-20monthsofageandsafetyandimmunogenicityofaboosterdoseofacombinedDTaP-IPV//PRP~Tvaccinecomparedtoseparatevaccines(DTaP,PRP~TandIPV)followingprimaryvaccinationofhealthyinfantsinthePeople'sRepublicofChina2011(50)11.TregnaghiMW;ZambranoB;Santos-LimaEImmunogenicityandsafetyofaninvestigationalhexavalentdiphtheria-tetanus-acellularpertussis-inactivatedpoliovirus-hepatitisB-HaemophilusinfluenzaeBconjugatecombinedvaccineinhealthy2-,4-,and6-month-oldArgentineaninfants2011(06)12.MacíasM;LanataCF;ZambranoBSafetyandimmunogenicityofaninvestigationalfullyliquidhexavalent:DTaPIPVHepBPRPTvaccineat2,4,6monthsofagecomparedtolicensedvaccinesinLatinAmerica201213.MadhiSA;MithaI;CutlandCImmunogenicityandsafetyofaninvestigationalfullyliquidhexavalentcombinationvaccineversuslicensedcombinationvaccinesat6,10and14weeksofageinhealthySouthAfricaninfants2011(04)14.KosalaraksaP;ThisyakornU;BenjaponpitakSImmunogenicityandsafetystudyofanewDTaP-IPV-HepBPRP-TcombinedvaccinecomparedtoalicensedDTaP-IPV-HepB//PRP-Tcomparator,bothconcomitantlyadministeredwitha7-valentpneumococcalconjugatevaccineat2,4,and6monthsofageinThaiinfants2011(04)15.HalperinSA;LangleyJM;HesleyTMSafetyandimmunogenicityoftwoformulationsofahexavalentdiphtheriatetanus-acellularpertussis-inactivatedpoliovirus-Haemophilusinfluenzaeconjugate-hepatitisBvaccinein15to18-month-oldchildren2005(06)16.HalperinSA;TapieroB;Diaz-MitomaFSafetyandimmunogenicityofahexavalentdiphtheria-tetanus-acellularpertussis-inactivatedpoliovirus-Haemophilusinfluenzaebconjugate-hepatitisBvaccineat2,3,4,and12-14monthsofage[外文期刊]2009(19)17.张庶民;侯启明;马霄吸附全细胞百白破乙肝四联疫苗效果观察[期刊论文]-中国公共卫生2003(09)18.李贵凡;郑海发;尹珊珊无细胞百白破b型流感嗜血杆菌联合疫苗的研制2008(09)19.EdwardsKM;MeadeBD;DeckerMDComparisonof13acellularpertussisvaccines:overviewandserologicresponse1995(3Pt2)20.GianniniG;RappuoliR;RattiGTheamino-acidsequenceoftwonon-toxicmutantsofdiphtheriatoxin:CRM45andCRM1971984(10)21.GreenbergDP;WongVK;PartridgeSSafetyandimmunogenicityofacombinationdiphtheria-tetanustoxoidsacellularpertussis-hepatitisBvaccineadministeredattwo,fourandsixmonthsofagecomparedwithmonovalenthepatitisBvaccineadministeredatbirth,onemonthandsixmonthsofage2002(08)22.GiammancoG;MoiraghiA;ZottiCSatetyandimmunogenicityofacombineddiphtheria-tetanus-acellularpertussis-hepatitisBvaccineadministeredaccordingtotwodifferentprimaryvaccinationschedules.MulticenterWorkingGroup1998(07)23.GylcaR;GylcaV;BenesOAnewDTPa-HBV-IPVvaccineco-administeredwithHib,comparedtoacommerciallyavailableDTPw-IPV/Hibvaccineco-administeredwithHBV,givenat6,10and14weeksfollowingHBVatbirth2000(7/8)引用本文格式:卫辰.侯启明.张庶民.陈平纡.马霄以百白破疫苗为基础的联合疫苗研究进展和展望[期刊论文]-中华预防医学杂志2012(9)

1 / 6
下载文档,编辑使用

©2015-2020 m.777doc.com 三七文档.

备案号:鲁ICP备2024069028号-1 客服联系 QQ:2149211541

×
保存成功